Research ArticleClinical Investigation
The Added Value of 18F-FDG PET/CT Compared with 68Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer
Ruohua Chen, Yining Wang, Yinjie Zhu, Yiping Shi, Lian Xu, Gang Huang and Jianjun Liu
Journal of Nuclear Medicine January 2022, 63 (1) 69-75; DOI: https://doi.org/10.2967/jnumed.120.262250
Ruohua Chen
1Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and
Yining Wang
1Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and
Yinjie Zhu
2Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Yiping Shi
1Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and
Lian Xu
1Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and
Gang Huang
1Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and
Jianjun Liu
1Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 1
January 1, 2022
The Added Value of 18F-FDG PET/CT Compared with 68Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer
Ruohua Chen, Yining Wang, Yinjie Zhu, Yiping Shi, Lian Xu, Gang Huang, Jianjun Liu
Journal of Nuclear Medicine Jan 2022, 63 (1) 69-75; DOI: 10.2967/jnumed.120.262250